PHARMAZEUTISCHE FORMULIERUNG

Patent europeic · EP4021405 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP4021405
Numer da la dumonda
EP20764963
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
27-08-2020
Publitgà
06-07-2022
Concedì
06-11-2024
Stritgà
24-03-2026
Motiv
Taxa annuala betg pajada
Classas IPC
A61K 9/00 (2006.01)
A61K 47/02 (2006.01)
A61K 47/26 (2006.01)
A61K 47/32 (2006.01)
A61K 47/36 (2006.01)
A61K 47/38 (2006.01)
A61K 47/40 (2006.01)
A61K 31/135 (2006.01)
Prioritad
GB 201912505 30.08.2019
Dumonda PCT
PCT/EP2020/073940 27.08.2020
Publicaziun PCT
WO2021/037960 04.03.2021
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 24-03-2026

    Stritgà, taxa betg pajada

    Status of protective title
    Active → Cancelled
    Cancellation date
    24.03.2026
    Cause for cancellation
    Non-payment of renewal fee

    Published in Swissreg on 24.03.2026

  2. 17-09-2025

    Midada

    Published in Swissreg on 17.09.2025

  3. 06-11-2024

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 06.11.2024

Partidas

Inventur

BOYER, Scott

754 50 Uppsala, SE

HÜBINETTE, Fredrik

754 50 Uppsala, SE

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.